Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 173Lymphoma, Non-Hodgkin 155Leukemia, Lymphocytic, Chronic, B-Cell 154Lymphoma, Large B-Cell, Diffuse 134Lymphoma, Follicular 131Lymphoma, Mantle-Cell 93Leukemia 68Lymphoma, B-Cell, Marginal Zone 67Waldenstrom Macroglobulinemia 49Burkitt Lymphoma 43Lymphoma, B-Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Hodgkin Disease 36Recurrence 24Lymphoma, Large-Cell, Immunoblastic 24Neoplasms 15Myelodysplastic Syndromes 15Lymphoma, Large-Cell, Anaplastic 15Multiple Myeloma 13Leukemia, Myeloid, Acute 12Lymphoma, T-Cell, Cutaneous 9Lymphoma, Extranodal NK-T-Cell 9Leukemia, Hairy Cell 9Intraocular Lymphoma 9Hematologic Neoplasms 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Immunoblastic Lymphadenopathy 8Sezary Syndrome 7Mycosis Fungoides 7Lymphoma, T-Cell 7

Interventions

Valganciclovir 2Rituximab 2tocilizumab 1human papillomavirus vaccine, L1 type 16, 18 1Zidovudine 1Watchful Waiting 1Vincristine 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Sugars 1Rapid Diagnostic Tests 1Prednisone 1Observation 1Methotrexate 1Maltose 1Light Coagulation 1Leucovorin 1Laser Therapy 1Interviews as Topic 1Interferon-alpha 1Imiquimod 1Fluorouracil 1Filgrastim 1Etoposide 1Enzyme-Linked Immunosorbent Assay 1Electrocoagulation 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Acquired Immunodeficiency Syndrome × Rituximab × Clear all
NCT00006436 2025-12-30

EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
68 enrolled 24 charts
Lymphoid

Acquired Immunodeficiency Syndrome, Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related

NCT00267865 2020-06-01

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
12 enrolled 15 charts

Acquired Immunodeficiency Syndrome, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡